Menu Close

Dr. Kahl on the Potential of CAR T-Cell Therapy in MCL

Brad Kahl, MD, professor in the Department of Medicine, Washington University School of Medicine in St. Louis, Siteman Cancer Center, discusses the potential of chimeric antigen receptor (CAR) T-cell therapy in mantle cell lymphoma (MCL). There is a lot of … (본문 전체 8/3/2018 6:13 AM)